Natco Pharma promoter sells shares in open market

Satya Vani Nannapaneni, a member of Natco Pharma Limited's promoter group, disclosed the sale of 23,000 equity shares in the open market on September 16, 2025. This transaction reduced Nannapaneni's total holding from 402,851 equity shares, representing 0.22% of the total share capital, to 379,851 equity shares, or 0.21%.

The shares were sold as part of a disclosure mandated by SEBI Regulations 29(2) and Form C of the Prohibition of Insider Trading Regulations, 2015. The sale accounted for a 0.01% change in Nannapaneni's holding in Natco Pharma Limited. The company's shares are listed on both the National Stock Exchange and the Bombay Stock Exchange.